Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to 48.68%.

  • Nutex Health's EBITDA Margin rose 364200.0% to 48.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.58%, marking a year-over-year increase of 399100.0%. This contributed to the annual value of 27.23% for FY2024, which is 400600.0% up from last year.
  • Per Nutex Health's latest filing, its EBITDA Margin stood at 48.68% for Q3 2025, which was up 364200.0% from 13.8% recorded in Q2 2025.
  • Nutex Health's 5-year EBITDA Margin high stood at 63.12% for Q3 2021, and its period low was 1509.7% during Q3 2022.
  • Over the past 5 years, Nutex Health's median EBITDA Margin value was 6.96% (recorded in 2024), while the average stood at 75.86%.
  • As far as peak fluctuations go, Nutex Health's EBITDA Margin crashed by -15728200bps in 2022, and later skyrocketed by 15083900bps in 2023.
  • Quarter analysis of 5 years shows Nutex Health's EBITDA Margin stood at 24.51% in 2021, then plummeted by -144bps to 10.76% in 2022, then plummeted by -249bps to 37.53% in 2023, then skyrocketed by 218bps to 44.33% in 2024, then rose by 10bps to 48.68% in 2025.
  • Its last three reported values are 48.68% in Q3 2025, 13.8% for Q2 2025, and 38.09% during Q1 2025.